Hemodialysis acutely altered interferon-gamma release assay test result and immune cell profile

Denise Utami Putri; Chia Ling Chen; Cheng Hui Wang; Yuh Mou Sue; Po Chun Tseng; Chiou Feng Lin; Ching Wen Tsai; Yi Jun Liu; Chih Hsin Lee

doi:10.1016/j.jmii.2021.03.022

Hemodialysis acutely altered interferon-gamma release assay test result and immune cell profile

Denise Utami Putri, Chia Ling Chen, Cheng Hui Wang, Yuh Mou Sue, Po Chun Tseng, Chiou Feng Lin, Ching Wen Tsai, Yi Jun Liu, Chih Hsin Lee

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Patients receiving hemodialysis (HD) are at risk of TB development. IGRA-positive patients showed significant decrease in quantitative IGRA result with alterations in CD3⁺CD4⁺CD45RO⁺, NK cell, and monocyte subsets immediately upon HD procedure. Our result suggested that the timing of IGRA testing is crucial in end-stage renal disease population.

Original language	English
Pages (from-to)	332-335
Number of pages	4
Journal	Journal of Microbiology, Immunology and Infection
Volume	55
Issue number	2
DOIs	https://doi.org/10.1016/j.jmii.2021.03.022
Publication status	Published - Apr 2022

Keywords

End stage renal disease
Hemodialysis
IGRA variability
Interferon gamma-release assay
Peripheral immune profile

ASJC Scopus subject areas

Immunology and Allergy
General Immunology and Microbiology
Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jmii.2021.03.022

Cite this

@article{09eb0068e58e4615aa8ef06beafc6be8,

title = "Hemodialysis acutely altered interferon-gamma release assay test result and immune cell profile",

abstract = "Patients receiving hemodialysis (HD) are at risk of TB development. IGRA-positive patients showed significant decrease in quantitative IGRA result with alterations in CD3+CD4+CD45RO+, NK cell, and monocyte subsets immediately upon HD procedure. Our result suggested that the timing of IGRA testing is crucial in end-stage renal disease population.",

keywords = "End stage renal disease, Hemodialysis, IGRA variability, Interferon gamma-release assay, Peripheral immune profile",

author = "Putri, {Denise Utami} and Chen, {Chia Ling} and Wang, {Cheng Hui} and Sue, {Yuh Mou} and Tseng, {Po Chun} and Lin, {Chiou Feng} and Tsai, {Ching Wen} and Liu, {Yi Jun} and Lee, {Chih Hsin}",

note = "Funding Information: This work was financially supported by the Wan Fang Hospital, Taipei Medical University ( 107TMU-WFH-05 ) and the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan ( DP2-109-21121-01-I-082 ). Publisher Copyright: {\textcopyright} 2021",

year = "2022",

month = apr,

doi = "10.1016/j.jmii.2021.03.022",

language = "English",

volume = "55",

pages = "332--335",

journal = "Journal of Microbiology, Immunology and Infection",

issn = "1684-1182",

publisher = "Lippincott Williams & Wilkins Asia",

number = "2",

}

TY - JOUR

T1 - Hemodialysis acutely altered interferon-gamma release assay test result and immune cell profile

AU - Putri, Denise Utami

AU - Chen, Chia Ling

AU - Wang, Cheng Hui

AU - Sue, Yuh Mou

AU - Tseng, Po Chun

AU - Lin, Chiou Feng

AU - Tsai, Ching Wen

AU - Liu, Yi Jun

AU - Lee, Chih Hsin

N1 - Funding Information: This work was financially supported by the Wan Fang Hospital, Taipei Medical University ( 107TMU-WFH-05 ) and the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan ( DP2-109-21121-01-I-082 ). Publisher Copyright: © 2021

PY - 2022/4

Y1 - 2022/4

N2 - Patients receiving hemodialysis (HD) are at risk of TB development. IGRA-positive patients showed significant decrease in quantitative IGRA result with alterations in CD3+CD4+CD45RO+, NK cell, and monocyte subsets immediately upon HD procedure. Our result suggested that the timing of IGRA testing is crucial in end-stage renal disease population.

AB - Patients receiving hemodialysis (HD) are at risk of TB development. IGRA-positive patients showed significant decrease in quantitative IGRA result with alterations in CD3+CD4+CD45RO+, NK cell, and monocyte subsets immediately upon HD procedure. Our result suggested that the timing of IGRA testing is crucial in end-stage renal disease population.

KW - End stage renal disease

KW - Hemodialysis

KW - IGRA variability

KW - Interferon gamma-release assay

KW - Peripheral immune profile

UR - http://www.scopus.com/inward/record.url?scp=85109111160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85109111160&partnerID=8YFLogxK

U2 - 10.1016/j.jmii.2021.03.022

DO - 10.1016/j.jmii.2021.03.022

M3 - Article

C2 - 34175241

AN - SCOPUS:85109111160

SN - 1684-1182

VL - 55

SP - 332

EP - 335

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

IS - 2

ER -

Hemodialysis acutely altered interferon-gamma release assay test result and immune cell profile

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this